People · Operator
Named in public records as an officer, director or promoter · active 2017–2024 · Biotechnology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NanoVibronix, Inc. | — | Biotechnology | Series A | $31.9M | $106.4M | 2017 |
| Poet Technologies Inc. | — | Software / Tech | Series A | $6.7M | $30.2M | 2021 |
Thomas Mika at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Thomas Mika on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Murphy | 1 | 15 |
| STEPHEN BROWN | 1 | 8 |
| James Lee | 1 | 5 |
| Don Listwin | 1 | 5 |
| James Cardwell | 1 | 4 |
| Ira Greenstein | 1 | 3 |
| Thomas R Mika | 1 | 2 |
| Paul Packer | 1 | 2 |
| Jean-Louis Malinge | 1 | 2 |
| Harold Jacob | 1 | 2 |
| William Stern | 1 | 2 |
| Yong Meng Lee | 1 | 1 |
| Glen Riley | 1 | 1 |
| Raju Kankipati | 1 | 1 |
| Theresa Lan Ende | 1 | 1 |
| Chris Tsiofas | 1 | 1 |
| Mohandas Warrior | 1 | 1 |
| Suresh Venkatesan | 1 | 1 |
| Maria R. Schroeder | 1 | 1 |
| Christopher Fashek | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.